The inability to handle recursion hampers AI's performance in tasks. In particular, AI can fail in programming tasks where some bit of code repeats a smaller, atomic version of the same code.

Recursion Pharmaceuticals is laying off a fifth of its workforce in connect with a previously announced streamlining of the AI biotech’s pipeline.

Recursion’s pipeline shuffle follows the company’s acquisition of AI development peer Exscientia late last year.